| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.02T | 916.62B | 678.64B | 664.50B | 1.06T |
| Gross Profit | 919.19B | 908.77B | 678.64B | 664.50B | 1.06T |
| EBITDA | 221.61B | 207.86B | 163.69B | 183.38B | 184.18B |
| Net Income | 131.29B | 126.61B | 85.67B | 111.01B | 101.62B |
Balance Sheet | |||||
| Total Assets | 13.90T | 12.96T | 11.58T | 11.01T | 10.14T |
| Cash, Cash Equivalents and Short-Term Investments | 269.72B | 950.37B | 797.92B | 746.52B | 630.51B |
| Total Debt | 2.61T | 1.40T | 1.49T | 1.48T | 1.59T |
| Total Liabilities | 12.49T | 11.65T | 10.35T | 9.82T | 9.06T |
| Stockholders Equity | 1.00T | 928.60B | 899.01B | 869.19B | 812.40B |
Cash Flow | |||||
| Free Cash Flow | 655.67B | 375.80B | 352.59B | 467.90B | 77.93B |
| Operating Cash Flow | 663.81B | 382.47B | 360.40B | 476.78B | 90.12B |
| Investing Cash Flow | -689.73B | -416.25B | -104.00B | -215.76B | 27.93B |
| Financing Cash Flow | 199.24B | 30.95B | -222.06B | -230.87B | -136.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$1.04T | 4.51 | 31.07% | 3.42% | 17.69% | 126.41% | |
71 Outperform | HK$389.47B | 9.89 | 18.91% | 3.28% | 15.08% | 23.13% | |
70 Outperform | HK$905.29B | 17.34 | 15.16% | 2.16% | 5.65% | 30.47% | |
70 Outperform | HK$189.23B | 4.31 | 38.67% | 5.24% | 49.90% | 203.77% | |
68 Neutral | HK$343.67B | 5.96 | 15.71% | 3.05% | 9.40% | 79.93% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | HK$1.14T | 8.07 | 14.77% | 4.25% | 10.20% | 19.74% |